Correvio Pharma (CORV)

[surf1944]

9:01AM Cardiome Pharma announces the transfer of European Marketing Authorization from Merck (MKGAY.PK) (CRME) 2.01 : Co announces adoption of the decision by the European Commission of the transfer of the centrally-approved marketing authorisation for BRINAVESS from Merck Sharp & Dohme to Cardiome. The decision marks Cardiome's assumption of responsibilities as the new marketing authorization holder for BRINAVESS in the member states of the European Union.

Cardiome and Merck (MKGAY.PK) will continue to work together until September 15, 2013 to finalize the organizational arrangement for transfer of all responsibilities, including batch release, and operational management of SPECTRUM, the post-approval safety study.